Tumor necrosis factors and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human tumor necrosis factor receptor designated as "Ztnfr12."

 
Web www.patentalert.com

< Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

> Polynucleotides encoding cytokine receptor zcytor19

> Methods and compositions for treating hepatitis C virus
~ 00554